glp-1/gip/glucagon triple agonist name Strategic Design of GLP-1R/GCGR/GIPR Agonists with Varied Receptor Potency: Achieving Comparable Glycemic and Weight Reduction Effects Structural insights into the triple

Gamma-glutamyltransferase 1 promotes clear cell renal cell carcinoma initiation and progression

Multiple organ protection models PLoS ONE Safety Data Safety Profile from Research Preclinical Safety Summary Toxicity (in vitro)None at research doses Dermal applicationExtensively safety-tested Cu deliveryPhysiological levels 50+ year researchNo serious concerns Regulatory & Risk Considerations FDA statusNot approved therapeutically Injectable human dataVery limited Copper overloadTheoretical at high doses Long-term systemicNot studied GHK-Cu has an excellent dermatological safety record in topical applications

The main statistical analyses were conducted using the R package TwoSampleMR 0.5.5 (20)

To verify the functions of these overlapping genes, we conducted KEGG enrichment analysis and found that these genes were significantly enriched in the VEGF signaling pathway, FoxO signaling pathway, MAPK signaling pathway, mTOR signaling pathway, and Wnt signaling pathway (Figure 1B)

Note: We have no affiliation with Joe Rogan - this article is based on publicly shared information.